The effect of fludarabine on interferon-γ production by lymphold cells from healthy donors and patients with B-cell chronic lymphocytic leukemia

Haematologica

Volumn 91, Issue 4, 2006, Pages 574-576

  Gamberale, Romina ^a,b,d   Fernández Calotti, Paula ^a,b   Sánchez Ávalos, Julio ^c   Alberto, María Fabiana ^a   Geffner, Jorge ^a,b   Giordano, Mirta ^a,b  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^d ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Autoimmune hemolytic anemia; Fludarabine; IFN production

Indexed keywords

CHLORAMBUCIL; DEXAMETHASONE; FLUDARABINE; GAMMA INTERFERON; IONOMYCIN;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B CELL LEUKEMIA; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; IN VITRO STUDY; LYMPHOID CELL; PROTEIN SYNTHESIS;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; CASE-CONTROL STUDIES; HUMANS; INTERFERON TYPE II; LEUKEMIA, B-CELL, CHRONIC; LYMPHOCYTES; VIDARABINE;

EID: 33646014761     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Keating MJ, Kantarjian H, Talpaz M, Redman J, Koller C, Barlogie B, et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 1989;74:19-25.
2. Mauro FR, Foa R, Cerretti R, Giannarelli D, Coluzzi S, Mandelli F, et al. Autoimmune hemolytic anemia in chronic Iymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 2000;95:2786-92.
3. Elson CJ, Barker RN. Helper T cells in antibody-mediated, organ-specific autoimmunity. Curr Opin Immunol 2000;12:664-9.
4. Fagiolo E, Toriani-Terenzi C. Th1 and Th2 cytokine modulation by IL-10/IL-12 imbalance in autoimmune haemolytic anaemia (AIHA). Autoimmunity 2002;35:39-44.
5. Hall AM, Ward FJ, Vickers MA, Stott LM, Urbaniak SJ, Barker RN. Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood 2002;100:4529-36.
6. Meite M, Leonard S, El Azami-El Idrissi M, Izui S, Masson PI, Coutelier JP. Exacerbation of autoantibody-mediated hemolytic anemia by viral infection. J Virol 2000;74:6045-9.
7. Fernández-Calotti P, Gamberale R, Costas M, Sánchez-Avalos J, Geffner J, et al. Fludarabine induces pro-inflammatory activation of human monocytic cells through a MAPK/ERK pathway. Int Immunopharmacol 2006;(in press).
8. Ravandi F, O'Brien S. Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunol Immunother 2005;16:1-13.
9. Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 1999;5:444-7.
10. Martinez-Lostao L, Briones J, Forne I, Martinez-Gallo M, Ferrer B, Sierra J, et al. Role of STAT-1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-CLL. Leuk Lymphoma 2005;46:435-42.